CONGRATULATIONS FOR 2021 ACHIEVEMENTS!
|
Congratulations to Ford lab alum Christie Towers on her new faculty position at The Salk Institute for Biological Studies! Christie graduated from the Ford lab with a PhD in Molecular Biology in 2016, and then completed her postdoctoral fellowship in Andrew Thorburn's lab working on autophagy. She starts her Assistant Prof position summer of 2021!
|
CONGRATULATIONS FOR 2020 ACHIEVEMENTS!
|
|
Ford Lab members go Over the Edge to raise money for cancer research funded by the Cancer League of Colorado! We all had to overcome some fears for this one!
|
Hengbo published three papers this year, including two on which he was first author (in Cancer Research and Oncogene). He was invited to give a talk at the Experimental Biology Meeting in San Diego for his work (had to give a virtual talk due to COVID)...
|
Congratulations to Hengbo for his successful thesis defense. The virtual defense (first ever in the lab) and virtual after party will be events to remember. Hengbo was awarded the Best Graduate Dissertation Award for his thesis work around "Targeting the SIX1/EYA Complex in Breast Cancer Metastasis". We wish him the best of luck as he moves on to Harvard for his postdoctoral work!
|
CONGRATULATIONS FOR 2019 ACHIEVEMENTS!
Congratulations to Mike Oliphant for successfully defending his PhD! Mike had another terrific year, publishing a first author paper in Cancer Research entitled " Six2 mediates late-stage metastasis via direct regulation of Sox2 and induction of a cancer stem cell program". We wish Mike the best success as he moves on to Harvard Medical School for his postdoctoral fellowship. We will miss him in the lab!
CONGRATULATIONS FOR 2018 ACHIEVEMENTS!
Congratulations to Hengbo for an incredible 2018! Hengbo received an F99/K00 award in 2018, published 3 papers (including a co-first author in Nature Communications, a second author in J Clin Invest, and a first author review in Int J Biochem Cell Bio). In addition, Hengbo won the Department of Pharmacology Student Award for Outstanding Achievement AND The Cancer Biology Graduate Program Outstanding Research Award! Way to go Hengbo!
Mike has had another great year. His first author paper on the role of Six2 in mediating a cancer stem cell phenotype was just accepted in Cancer Research, he won numerous awards such as the 2018 Minority Scholar in Cancer Research Award to attend the 2018 AACR national meeting (where he gave a talk!), the 2018 Top Poster in Cancer Research Award at the New England Science Symposium at Harvard Medical School, and a poster award at the University of Colorado 33rd Annual Student Research Forum. He has just accepted a postdoctoral position at Harvard Medical School with Joan Brugge and Senthil Muthuswamy. Exciting times are ahead for Mike (after he defends his thesis!)....
Congratulations to Becky on her publication this year in J Clin Invest related to Eya3-mediated immune suppression in breast cancer. The paper was highlighted in Cancer Discovery shortly after its publication! Congratulations also for your new job as a scientist at The Gates Biomanufacturing Facility working on immune therapies. The Ford lab wishes you the best in your new position!
CONGRATULATIONS FOR 2017 ACHIEVEMENTS!
Sept. 2017-Congratulations to Mike for receiving a prestigious F99/K00 award from The National Cancer Institute! This award gives Mike 2 years of funding to finish his Dissertation work in our lab, and then 4 years of funding in a postdoctoral position!
Nice shout-out to Mel from the ALSF regarding the postdoctoral fellowship grant she received in 2016 and the work she is doing on medulloblastoma!
Congratulations to Becky on her recent graduation (Dec. 2017)! Becky is moving on to a Scientist job at the Gates Biomanufacturing Center where she is working on CAR T-cell therapy. We wish her all the best!
Congrats to Hengbo on his recent publication in Nature Communications, as a co-first author along with Lingdi Zhang from the Zhao lab! Hengbo is shown here with his committee member, James DeGregori, after giving a talk at the King Symposium sponsored by the Department of Pathology and the Cancer Biology Graduate Program.
Congrats to Jessica for receiving a competitive Colorado Clinical Translational Sciences Initiative TSI predoctoral fellowship in 2017! As part of this fellowship, Jessica will continue to perform her work to understand the progression of rhabdomyosarcoma, using zebrafish, rodent, and human models, and will also gain some clinical insight into pediatric sarcomas through her shadowing of Tim Garrington at Children's Hospital, an Associate Professor in Pediatrics and Director of the Pedi-Heme Onc Fellowship Program.